Natasa Gisev
Natasa Gisev
National Drug and Alcohol Research Centre, UNSW Australia
Verified email at - Homepage
Cited by
Cited by
Interrater agreement and interrater reliability: key concepts, approaches, and applications
N Gisev, JS Bell, TF Chen
Research in Social and Administrative Pharmacy 9 (3), 330-338, 2013
The impact of opioid substitution therapy on mortality post‐release from prison: retrospective data linkage study
L Degenhardt, S Larney, J Kimber, N Gisev, M Farrell, T Dobbins, ...
Addiction 109 (8), 1306-1317, 2014
A synthesis of oral morphine equivalents (OME) for opioid utilisation studies
S Nielsen, L Degenhardt, B Hoban, N Gisev
Pharmacoepidemiology and drug safety 25 (6), 733-737, 2016
Trends in heroin and pharmaceutical opioid overdose deaths in Australia
A Roxburgh, WD Hall, T Dobbins, N Gisev, L Burns, S Pearson, ...
Drug and alcohol dependence 179, 291-298, 2017
Opioid substitution therapy as a strategy to reduce deaths in prison: retrospective cohort study
S Larney, N Gisev, M Farrell, T Dobbins, L Burns, A Gibson, J Kimber, ...
BMJ open 4 (4), 2014
The extent and correlates of community‐based pharmaceutical opioid utilisation in Australia
L Degenhardt, N Gisev, E Cama, S Nielsen, B Larance, R Bruno
Pharmacoepidemiology and drug safety 25 (5), 521-538, 2016
Comparing opioids: a guide to estimating oral morphine equivalents (OME) in research
S Nielsen, L Degenhardt, B Hoban, N Gisev
National Drug and Alcohol Research Centre, 2014
A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia
L Burns, N Gisev, S Larney, T Dobbins, A Gibson, J Kimber, B Larance, ...
Addiction 110 (4), 646-655, 2015
An expert panel assessment of comprehensive medication reviews for clients of community mental health teams
N Gisev, JS Bell, CL O’Reilly, A Rosen, TF Chen
Social psychiatry and psychiatric epidemiology 45 (11), 1071-1079, 2010
New psychoactive substances: challenges for drug surveillance, control, and public health responses
A Peacock, R Bruno, N Gisev, L Degenhardt, W Hall, R Sedefov, J White, ...
The Lancet 394 (10209), 1668-1684, 2019
Prevalence and incidence of prescription opioid analgesic use in Australia
S Lalic, J Ilomäki, JS Bell, MJ Korhonen, N Gisev
British journal of clinical pharmacology 85 (1), 202-215, 2019
Mortality associated with benzodiazepines and benzodiazepine-related drugs among community-dwelling older people in Finland: a population-based retrospective cohort study
N Gisev, S Hartikainen, TF Chen, M Korhonen, JS Bell
The Canadian Journal of Psychiatry 56 (6), 377-381, 2011
Predictors of persistent prescription opioid analgesic use among people without cancer in Australia
S Lalic, N Gisev, JS Bell, MJ Korhonen, J Ilomäki
British journal of clinical pharmacology 84 (6), 1267-1278, 2018
An ecological study of the extent and factors associated with the use of prescription and over-the-counter codeine in Australia
N Gisev, S Nielsen, E Cama, B Larance, R Bruno, L Degenhardt
European journal of clinical pharmacology 72 (4), 469-494, 2016
Defined daily doses (DDD) do not accurately reflect opioid doses used in contemporary chronic pain treatment
S Nielsen, N Gisev, R Bruno, W Hall, M Cohen, B Larance, G Campbell, ...
Pharmacoepidemiology and drug safety 26 (5), 587-591, 2017
Engagement with the criminal justice system among opioid‐dependent people: a retrospective cohort study
L Degenhardt, N Gisev, J Trevena, S Larney, J Kimber, L Burns, ...
Addiction 108 (12), 2152-2165, 2013
Pharmaceutical opioid use and harm in Australia: the need for proactive and preventative responses
B Larance, L Degenhardt, A Peacock, N Gisev, R Mattick, S Colledge, ...
Drug and alcohol review 37, S203-S205, 2018
To what extent do data from pharmaceutical claims under‐estimate opioid analgesic utilisation in Australia?
N Gisev, SA Pearson, EA Karanges, B Larance, NA Buckley, S Larney, ...
Pharmacoepidemiology and drug safety 27 (5), 550-555, 2018
If no-one stops me, I'll make the mistake again’: Changing prescribing behaviours through feedback; A Perceptual Control Theory perspective
J Ferguson, C Keyworth, MP Tully
Research in Social and Administrative Pharmacy 14 (3), 241-247, 2018
A cost‐effectiveness analysis of opioid substitution therapy upon prison release in reducing mortality among people with a history of opioid dependence
N Gisev, M Shanahan, DJ Weatherburn, RP Mattick, S Larney, L Burns, ...
Addiction 110 (12), 1975-1984, 2015
The system can't perform the operation now. Try again later.
Articles 1–20